These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24906046)

  • 1. Reply: To PMID 23983134.
    Bredemeier M
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1593-6. PubMed ID: 24906046
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).
    Conway R; Carey JJ
    Rheumatology (Oxford); 2011 Mar; 50(3):631-2; author reply 632-3. PubMed ID: 21172927
    [No Abstract]   [Full Text] [Related]  

  • 3. Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?
    van Herwaarden N; van der Maas A; Jansen TL; Dutmer EA; Hartkamp A; van Riel PL; Kievit W; van den Bemt BJ; den Broeder AA
    Scand J Rheumatol; 2013; 42(3):251-2. PubMed ID: 23496283
    [No Abstract]   [Full Text] [Related]  

  • 4. Prompt efficacy of very low-dose rituximab on monoclonal B lymphocytosis in a rheumatoid arthritis patient.
    Bruzzese V; Marrese C; Hassan C; Andriani A; Zullo A
    Int J Rheum Dis; 2013 Dec; 16(6):764-5. PubMed ID: 24200218
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rituximab: Half dose with full strength?].
    Feist E
    Z Rheumatol; 2014 Nov; 73(9):856-7. PubMed ID: 24942603
    [No Abstract]   [Full Text] [Related]  

  • 6. More or less rituximab? Biology and clinic, regulators and researchers.
    van Vollenhoven RF
    Arthritis Rheum; 2011 Mar; 63(3):594-6. PubMed ID: 21360487
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab?
    Boumans MJ; Vos K; Gerlag DM; Tak PP
    Ann Rheum Dis; 2012 Mar; 71(3):472-3. PubMed ID: 21908451
    [No Abstract]   [Full Text] [Related]  

  • 8. Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al.
    Bredemeier M
    Ann Rheum Dis; 2014 Jun; 73(6):e33. PubMed ID: 24595549
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Dr Bredemeier's letter.
    Vital EM; Dass S; Buch MH; Rawstron AC; Emery P
    Ann Rheum Dis; 2014 Jun; 73(6):e34. PubMed ID: 24632007
    [No Abstract]   [Full Text] [Related]  

  • 10. Choosing the right rituximab dose for the right patient: comment on the article by Bredemeier et al.
    Vital EM; Md Yusof MY; Emery P
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1591-3. PubMed ID: 24905770
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
    Willeke P; Becker H; Schlüter B; Pavenstäd H; Mickholz E; Wierichs C; Gaubitz M; Schotte H
    Scand J Rheumatol; 2012 May; 41(3):242-3. PubMed ID: 22401537
    [No Abstract]   [Full Text] [Related]  

  • 12. Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.
    Meyer A; Theulin A; Chatelus E; Argemi X; Sordet C; Javier RM; Hansmann Y; Sibilia J; Gottenberg JE
    Ann Rheum Dis; 2012 Jun; 71(6):1094-5. PubMed ID: 22302315
    [No Abstract]   [Full Text] [Related]  

  • 13. [The quality of life in patients with rheumatoid arthritis treated with rituximab].
    Mazurov VI; Avlokhova SR
    Klin Med (Mosk); 2014; 92(12):42-8. PubMed ID: 25980298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F; Koehm M; Burkhardt H
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply: To PMID 22886739.
    Simard JF; Neovius M; Askling J
    Arthritis Rheum; 2013 Jun; 65(6):1671-2. PubMed ID: 23508884
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis.
    Iaccheri B; Androudi S; Bocci EB; Gerli R; Cagini C; Fiore T
    Ocul Immunol Inflamm; 2010 Jun; 18(3):223-5. PubMed ID: 20482403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations on the use of rituximab for patients with rheumatoid arthritis].
    Rubbert-Roth A; Burmester G;
    Z Rheumatol; 2008 Nov; 67(7):609-13. PubMed ID: 18830700
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rituximab treatment of rheumatoid arthritis: new evidence].
    Nasonov EL
    Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].
    Nasonov EL
    Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066
    [No Abstract]   [Full Text] [Related]  

  • 20. Dr. Hardcastle, et al reply.
    Hardcastle SA
    J Rheumatol; 2013 Jul; 40(7):1231. PubMed ID: 23980260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.